3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
9
Neoplasms
7
Breast Neoplasms
6
Pancreatic Neoplasms
3
Malnutrition
3
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Prostatic Neoplasms
2
Pharyngeal Neoplasms
2
Obesity
2
Lung Neoplasms
2
Liver Neoplasms
2
Diabetes Mellitus, Type 2
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Weight Loss
1
Undefined
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neurotoxicity Syndromes
1
Mouth Neoplasms
1
Lung Diseases
1
Liver Diseases
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Interventions
Resistance Training
6
Exercise
5
Docosahexaenoic Acids
3
maltodextrin
2
Nutrition Assessment
2
Drug Therapy
2
nicotinamide-beta-riboside
1
fucoidan
1
Whey Proteins
1
Wearable Electronic Devices
1
Soybean Proteins
1
Relaxation Therapy
1
Olive Oil
1
Nutritional Status
1
Nutrition Therapy
1
Glutamine
1
Gloves, Surgical
1
Geriatric Assessment
1
Diet Therapy
1
Diet
1
Creatine
1
Control Groups
1
Caloric Restriction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sarcopenia
×
Nutritional Status
×
Clear all
NCT05281211
2025-04-18
NEXPREM
San Camillo Hospital, Rome
Phase NA
Completed
70 enrolled